Pediatric Nephrology

, Volume 27, Issue 7, pp 1157–1164 | Cite as

Early cardiac dysfunction in pediatric patients on maintenance dialysis and post kidney transplant

  • Rossana Malatesta-Muncher
  • Janaka Wansapura
  • Michael Taylor
  • Diana Lindquist
  • Kan Hor
  • Mark Mitsnefes
Original Article

Abstract

Background

Children with advanced chronic kidney disease (CKD) frequently develop left ventricular (LV) hypertrophy. The extent of hypertrophy that results in cardiac dysfunction is unknown. Systolic function, routinely determined by ejection fraction (EF), is usually preserved in these patients. However, a decrease in EF represents an advanced cardiac dysfunction. We used cardiac magnetic resonance (CMR) and phosphorus-31 MR spectroscopy (31P MRS) to assess markers of cardiac dysfunction in young CKD patients.

Methods

Ten dialysis and ten post-transplant patients completed the study. The outcomes were peak LV myocardial circumferential strain (Ecc); myocardial T2 relaxation time and full width at half maximum (FWHM) of T2 distribution; and phosphocreatinine/adenosine triphosphate (PCr/ATP) to measure muscle energy metabolism. Healthy controls were used for comparison.

Results

All patients had normal EF; nine (45%) had low Ecc. Ecc was lower in dialysis versus transplant (p < 0.0001) patients and inversely correlated with LV mass index, r = −0.47, p = 0.04. Patients had higher T2 (p = 0.056) and FWHM (p = 0.01) than controls. T2 levels were positively correlated with LVM index (r = 0.46, p = 0.04). PCr/ATP was lower in patients than in controls (p = 0.02).

Conclusion

Young patients with advanced CKD and normal EF have early cardiac changes. Association of these abnormalities with increased left ventricular mass (LVM) index suggests development of maladaptive hypertrophy.

Keywords

Cardiac MRI Children Chronic kidney disease Dialysis Transplant Cardiovascular 

References

  1. 1.
    Bock JS, Gottlieb SS (2010) Cardiorenal syndrome: new perspectives. Circulation 121:2592–2600PubMedCrossRefGoogle Scholar
  2. 2.
    Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Stancanelli B, Cataliotti A, Malatino LS (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65:1492–1498PubMedCrossRefGoogle Scholar
  3. 3.
    Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE (1998) Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 54:1720–1725PubMedCrossRefGoogle Scholar
  4. 4.
    Siedlecki A, Foushee M, Curtis JJ, Gaston RS, Perry G, Iskandrian AE, de Mattos AM (2007) The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation 84:1610–1617PubMedCrossRefGoogle Scholar
  5. 5.
    Stack AG, Bloembergen WE (2001) Study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. Am J Kidney Dis 38:992–1000PubMedCrossRefGoogle Scholar
  6. 6.
    Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS (2000) Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol 15:1029–1037CrossRefGoogle Scholar
  7. 7.
    Zoccali C, Benedetto FA, Tripepi G, Mallamaci F, Rapisarda F, Seminara G, Bonanno G, Malatino LS (2006) Left ventricular systolic function monitoring in asymptomatic dialysis patients: a prospective cohort study. J Am Soc Nephrol 17:1460–1465PubMedCrossRefGoogle Scholar
  8. 8.
    Mitsnefes MM, Daniels SR, Schwartz SM, Khoury P, Meyer RA, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898–902PubMedCrossRefGoogle Scholar
  9. 9.
    Mitsnefes MM, Barletta GM, Dresner IG, Chand DH, Geary D, Lin JJ, Patel H (2006) Severe cardiac hypertrophy and long-term dialysis: the Midwest Pediatric Nephrology Consortium study. Pediatr Nephrol 21:1167–1170PubMedCrossRefGoogle Scholar
  10. 10.
    Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Impaired left ventricular diastolic function in children with chronic renal failure. Kidney Int 65:1461–1466PubMedCrossRefGoogle Scholar
  11. 11.
    Mitsnefes MM, Kimball TR, Border WL, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2004) Abnormal cardiac function in children after renal transplantation. Am J Kidney Dis 43:721–726PubMedCrossRefGoogle Scholar
  12. 12.
    Palcoux JB, Palcoux MC, Jonan JM, Gourgand JM, Cassagnes J, Malpuech G (1982) Echocardiographic patterns in infants and children with chronic renal failure. Int J Pediatr Nephrol 3:311–314PubMedGoogle Scholar
  13. 13.
    Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR (1996) Left ventricular abnormalities in children, adolescents, and young adults with renal disease. Kidney Int 50:998–1006PubMedCrossRefGoogle Scholar
  14. 14.
    Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864–868PubMedCrossRefGoogle Scholar
  15. 15.
    National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRefGoogle Scholar
  16. 16.
    Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637PubMedCrossRefGoogle Scholar
  17. 17.
    Pöge U, Gerhardt T, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP (2005) MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant 5:1306–1311PubMedCrossRefGoogle Scholar
  18. 18.
    Osman NF, Kerwin WS, McVeigh ER, Prince JL (1999) Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn Reson Med 42:1048–1060PubMedCrossRefGoogle Scholar
  19. 19.
    Sarikouch S, Peters B, Gutberlet MB, Leismann B, Kelter-Kloepping A, Koerperich H, Kuehne T, Beerbaum P (2010) Sex-specific pediatric percentiles for ventricular size and mass as reference values for Cardiac MRI: assessment by steady-state free-precession and phase-contrast for MRI flow. Circ Cardiovasc Imaging 3:65–76PubMedCrossRefGoogle Scholar
  20. 20.
    Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R, Benson DW, Gottliebson WM (2009) Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 53:1204–1210PubMedCrossRefGoogle Scholar
  21. 21.
    Shivu GN, Abozguia K, Phan TT, Ahmed I, Henning A, Frenneaux M (2008) (31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: experiences at 3T. Eur J Radiol 73:255–259PubMedCrossRefGoogle Scholar
  22. 22.
    Vanhamme L, Sundin T, Hecke PV, Huffel SV (2001) MR spectroscopy quantitation: a review of time-domain methods. NMR Biomed 14:233–246PubMedCrossRefGoogle Scholar
  23. 23.
    Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, Kostler H, von Kienlin M, Harre K, Hahn D, Neubauer S (2002) Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40:1267–1274PubMedCrossRefGoogle Scholar
  24. 24.
    Wansapura JP, Hor KN, Mazur W, Fleck R, Hagenbuch S, Benson DW, Gottliebson WM (2010) Left ventricular T2 distribution in Duchenne muscular dystrophy. J Cardiovasc Magn Reson 8:12–14Google Scholar
  25. 25.
    Beer M (2004) Cardiac spectroscopy: techniques, indications and clinical results. Eur Radiol 14:1034–1047PubMedCrossRefGoogle Scholar
  26. 26.
    Ogimoto G, Sakurada T, Imamura K, Kuboshima S, Maeba T, Kimura K, Owada S (2003) Alteration of energy production by the heart in CRF patients undergoing peritoneal dialysis. Mol Cell Biochem 244:135–138PubMedCrossRefGoogle Scholar
  27. 27.
    Jung WF, Sieverding L, Breuer J, Hoess T, Widmaier S, Schmidt O, Bunse M, van Erckelens F, Apitz J, Lutz O, Dietze GD (1998) 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 97:2536–2542PubMedGoogle Scholar
  28. 28.
    Ridgway JP (2010) Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson 12:71PubMedCrossRefGoogle Scholar
  29. 29.
    O’Connor RD, Bashir A, Todd Cade W, Yarasheski KE, Gropler RJ (2009) 1H-magnetic resonance spectroscopy for quantifying myocardial lipid content in humans with the cardiometabolic syndrome. J Clin Hypertens 11:528–532CrossRefGoogle Scholar
  30. 30.
    Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D (2003) Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143:653–657PubMedCrossRefGoogle Scholar
  31. 31.
    Urheim S, Edvardsen T, Torp H, Angelsen B, Smiseth OA (2000) Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function. Circulation 102:1158–1164PubMedGoogle Scholar
  32. 32.
    Moore CC, McVeigh ER, Zerhouni EA (2000) Quantitative tagged magnetic resonance imaging of the normal human left ventricle. Top Magn Reson Imaging 11:359–371PubMedCrossRefGoogle Scholar
  33. 33.
    Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191–197PubMedCrossRefGoogle Scholar
  34. 34.
    Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van de Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 61:621–629PubMedCrossRefGoogle Scholar
  35. 35.
    McDonald SP, Craig JC, Australian and New Zealand Pediatric Nephrology Association, (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654–2662PubMedCrossRefGoogle Scholar
  36. 36.
    Green D, Roberts PR, New DI, Kalra PA (2011) Sudden cardiac death in hemodialysis patients: an in-depth review. Am J Kidney Dis 57:921–929PubMedCrossRefGoogle Scholar
  37. 37.
    Parekh RS, Plantinga LC, Kao WH, Meoni LA, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ (2008) The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 74:1335–1342PubMedCrossRefGoogle Scholar
  38. 38.
    Wang AY, Lam CW, Chan IH, Wang M, Lui SF, Sanderson JE (2010) Sudden cardiac death in end-stage renal disease patients: a 5-year prospective analysis. Hypertension 56:210–216PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2012

Authors and Affiliations

  • Rossana Malatesta-Muncher
    • 1
  • Janaka Wansapura
    • 2
  • Michael Taylor
    • 3
  • Diana Lindquist
    • 2
  • Kan Hor
    • 3
  • Mark Mitsnefes
    • 1
  1. 1.Division of Nephrology and HypertensionCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  2. 2.Division of RadiologyCincinnati Children’s Hospital Medical CenterCincinnatiUSA
  3. 3.Heart InstituteCincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations